Table of Contents
PPT Slide
Phase II Study Designs
Therapeutic Intent
Scientific Validity of Phase II Windows
Impact: Classic Phase II Trials
Not all agents active in classic phase II trials improve survival
Too early to judge impact of window phase II studies Long developmental cycle
Patient Benefits: Phase II Windows
Phase II Windows: Agent selection
Phase II Windows: Patient selection
Phase II Windows: Consent
Phase II Windows: Summary
Consensus meeting July 22, 1997 Points to Consider
Risks and Benefits
Informed Consent
Informed Consent
|
Author: Althea M Roberts
|